Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Operating Expenses: 2018-2024

Historic Operating Expenses for Burning Rock Biotech (BNR) over the last 7 years, with Dec 2024 value amounting to -$98.6 million.

  • Burning Rock Biotech's Operating Expenses fell 46.05% to $183.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$166.3 million, marking a year-over-year decrease of 129.46%. This contributed to the annual value of -$98.6 million for FY2024, which is 32.18% up from last year.
  • Per Burning Rock Biotech's latest filing, its Operating Expenses stood at -$98.6 million for FY2024, which was up 32.18% from -$145.4 million recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Operating Expenses peaked at -$98.6 million during FY2024, and registered a low of -$197.2 million during FY2022.
  • Moreover, its 3-year median value for Operating Expenses was -$145.4 million (2023), whereas its average is -$147.1 million.
  • As far as peak fluctuations go, Burning Rock Biotech's Operating Expenses crashed by 73.72% in 2020, and later spiked by 32.18% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Operating Expenses (Yearly) stood at -$111.3 million in 2020, then slumped by 63.70% to -$182.2 million in 2021, then decreased by 8.25% to -$197.2 million in 2022, then grew by 26.27% to -$145.4 million in 2023, then skyrocketed by 32.18% to -$98.6 million in 2024.